https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Brain-MS.jpg

Neurological Devices Market Size, Share & COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Neurovascular Catheters, Neuromodulation Devices, and 12 more

  • Year: 2022
  • Scope: 10 Years
  • Region: United States
  • Pages: 432
  • Published Date: 09/09/2022
  • Type: MedSuite

In 2021, the U.S. neurological devices market size was valued at $5.8 billion. Moving forwards, the market size is expected to increase at a growth rate of 5.9% to reach $8.6 billion in 2028.

The full report suite on the U.S. market for neurological devices includes cerebrospinal fluid
management, detachable coils, liquid embolics, neurovascular catheters, neurovascular
guidewires, neurovascular stents, balloon occlusion devices, aneurysm clips, neurovascular
thrombus management, neuromodulation devices, intrathecal pumps, stereotactic devices,
neuroendoscopes and ultrasonic aspirators.

MARKET DATA INCLUDED

  • Unit SalesAverage Selling PricesMarket Size & Growth Trends
  • Procedure Numbers
  • COVID-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2027, and Historical Data to 2017
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors

U.S. Neurological Device Market Insights

U.S. neurological device marketNeuromodulation devices comprise the largest segment for neurological devices, divided between
several competitors in the spinal cord stimulation and deep brain stimulation space. Most other
segments, including vagus nerve stimulation, gastric electric stimulation, dorsal root ganglion
stimulation and responsive neurostimulation, remain monopolized market segments at the time
of publication.

U.S. Neurological Device Market Share Insights

u.s. neurological device market sharesMedtronic has maintained its leading position in the neurological device market, but growing
competition has broken several of its monopolies across the market. Across the company’s vast
product catalogue, it now only maintains a monopoly in the gastric electric stimulation market,
with new competition working through the FDA approval process. In the liquid embolic, intrathecal
pump and stereotactic device markets, Medtronic still holds more than half of the market share.

MARKET SEGMENTATION SUMMARY

The analyses on each of the following markets can be purchased as separate reports, MedCores.

  • Cerebrospinal Fluid Management Market 
  • Detachable Coils Market 
  • Liquid Embolics Market 
  • Neurovascular Catheters Market 
  • Neurovascular Guidewires Market 
  • Neurovascular Catheter Market 
  • Neurovascular Stents Market
  • Balloon Occlusion Device Market 
  • Aneurysm Clips Market
  • Neurovascular Thrombus Management Market
  • Neuromodulation Devices Market
  • Intrathecal Pumps Market 
  • Stereotactic Devices Market 
  • Neuroendoscope Market 
  • Ultrasonic Aspirators Market

 RESEARCH SCOPE SUMMARY

Report Attribute Details
Region North America (United States)
Base Year  2021
Forecast  2022-2028
Historical Data  2018-2021
Quantitative Coverage Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, Disease Overviews.
Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

FREE Sample Report

TABLE OF CONTENTS  I
LIST OF FIGURES      XIV
LIST OF CHARTS      XXIII
EXECUTIVE SUMMARY  1
U S  NEUROLOGICAL DEVICE MARKET OVERVIEW     1
COMPETITIVE ANALYSIS  3
MARKET TRENDS  6
MARKET DEVELOPMENTS      8
PROCEDURE NUMBERS  9
MARKETS INCLUDED   10
KEY REPORT UPDATES  12
VERSION HISTORY   12
RESEARCH METHODOLOGY    13
Step 1: Project Initiation & Team Selection   13
Step 2: Prepare Data Systems and Perform Secondary Research 16
Step 3: Preparation for Interviews & Questionnaire Design 18
Step 4: Performing Primary Research   19
Step 5: Research Analysis: Establishing Baseline Estimates 21
Step 6: Market Forecast and Analysis   22
Step 7: Identify Strategic Opportunities     24
Step 8: Final Review and Market Release    25
Step 9: Customer Feedback and Market Monitoring  26
IMPACT OF COVID-19 ON THE U S  NEUROLOGICAL DEVICE MARKET 27
INTRODUCTION  27
ANALYSIS BY MARKET SEGMENT      29
Worst Case Scenario      29
Base Case Scenario  32
Best Case Scenario  35
DISEASE OVERVIEW     39
BASIC ANATOMY      39
DISEASE PATHOLOGY AND DISORDERS      41
Introduction  41
General Diagnostics and Neurosurgery  43
Tumor and Brain Cancer    45
Brain Arteriovenous Malformations    46
Ischemic Stroke     47
Brain Aneurysm     48
Disorders Related to Cerebrospinal Fluids and Intracranial Pressure    50
Hydrocephalus and Intracranial Pressure Disorder  50
Cerebral Edema      52
Indication for Neuromodulation   53
Traumatic Brain injury     55
PRODUCT ASSESSMENT      56
INTRODUCTION  56
PRODUCT PORTFOLIOS  56
Cerebrospinal Fluid Management     56
Detachable Coils     60
Liquid Embolics      62
Neurovascular Catheters    64
Neurovascular Guidewires      66
Neurovascular Stents      68
Balloon Occlusion Devices      70
Aneurysm Clip      72
Neurovascular Thrombus Management  74
Neuromodulation Devices     77
Introduction  77
Spinal Cord Stimulators  77
Vagus Nerve Stimulators      78
Deep Brain Stimulators  78
Gastric Electric Stimulators     78
Sacral Nerve Stimulators      79
Dorsal Root Ganglion Stimulation Market   80
Responsive Neurostimulation Market     80
Intrathecal Pumps      82
Stereotactic Devices     84
Neuroendoscopy Devices      87
Ultrasonic Aspiration Devices    90
REGULATORY ISSUES AND RECALLS     91
Cerebrospinal Fluid Management    91
Detachable Coils  92
Neurovascular Catheters      94
Neurovascular Stent     95
Balloon Occlusion Devices     96
Neuromodulation Devices     98
Neuroendoscopy  99
Stereotactic Devices     100
Ultrasonic Aspiration    102
Neurological Microscopes     103
Intrathecal Pumps      104
Mechanical Thrombectomy    105
CLINICAL TRIALS      106
Cerebrospinal Fluid Management    107
Detachable Coils  109
Liquid Embolics  111
Neurovascular Catheters     113
Neurovascular Guidewires     115
Neurovascular Stent     116
Neuromodulation devices     118
Neuroendoscopy      120
Stereotactic Devices     121
Ultrasonic Aspiration    123
Aneurysm Clip     125
Neurological Microscopes     126
Mechanical Thrombectomy    127
U S  NEUROLOGICAL DEVICE MARKET OVERVIEW 128
INTRODUCTION      128
Cerebrospinal Fluid Management    128
Interventional Neuroradiology   128
Neuromodulation  129
Neurosurgery      130
Neurovascular Thrombectomy   131
MARKET OVERVIEW & TREND ANALYSIS    132
DRIVERS AND LIMITERS      138
Market Drivers     138
Cerebrospinal Fluid Management     138
Interventional Neuroradiology      138
Neuromodulation  139
Neurosurgery   140
Neurovascular Thrombectomy      141
Market Limiters     142
Cerebrospinal Fluid Management     142
Interventional Neuroradiology      142
Neuromodulation  142
Neurosurgery   143
Neurovascular Thrombectomy      144
COMPETITIVE MARKET SHARE ANALYSIS     145
MERGERS AND ACQUISITIONS      154
COMPANY PROFILES  155
Abbott      155
B  Braun      156
Boston Scientific  157
Cerenovus  158
Integra LifeSciences     159
Codman & Shurtleff     159
LivaNova   160
Medtronic  161
MicroVention     162
Mizuho   163
Stryker      164
SWOT ANALYSIS   165
Abbott      166
B  Braun   167
Boston Scientific  168
Integra LifeSciences     169
LivaNova   170
Medtronic  171
MicroVention     172
Mizuho   173
Stryker      174
PROCEDURE NUMBERS     175
PROCEDURE ANALYSIS AND FORECAST     175
Cerebrospinal Fluid Shunting Procedures    178
Interventional Treatment of Saccular Aneurysm Procedures     180
Liquid Embolization of AVM Procedures    182
Neurovascular Thrombus Management Procedures 183
Neuromodulation Procedures   185
Spinal Cord Stimulation Procedures    188
Deep Brain Stimulation Procedures    189
Intrathecal Pump Procedures      190
Stereotactic Surgery Procedures     192
Ultrasonic Aspiration Procedures     193
CEREBROSPINAL FLUID MANAGEMENT MARKET 194
INTRODUCTION      194
MARKET OVERVIEW  196
MARKET ANALYSIS AND FORECAST    199
Cerebrospinal Fluid Shunt Market    199
Adjustable Pressure Cerebrospinal Fluid Shunt Market  202
Fixed Pressure Cerebrospinal Fluid Shunt Market  204
Cerebrospinal Fluid External Drainage System Market     206
Ventricular Drainage System Market   208
Lumbar and Ventricular Drainage System Market  210
DRIVERS AND LIMITERS      211
Market Drivers     211
Market Limiters     212
COMPETITIVE MARKET SHARE ANALYSIS     214
DETACHABLE COIL MARKET      219
INTRODUCTION      219
MARKET OVERVIEW  220
MARKET ANALYSIS AND FORECAST    223
Total Detachable Coil Market    223
Bare Platinum Detachable Coil Market  224
Coated Detachable Coil Market   225
DRIVERS AND LIMITERS      226
Market Drivers     226
Market Limiters     227
COMPETITIVE MARKET SHARE ANALYSIS     229
LIQUID EMBOLIC MARKET    233
INTRODUCTION      233
MARKET ANALYSIS AND FORECAST    234
DRIVERS AND LIMITERS      236
Market Drivers     236
Market Limiters     236
COMPETITIVE MARKET SHARE ANALYSIS     238
NEUROVASCULAR CATHETER MARKET    241
INTRODUCTION      241
MARKET OVERVIEW  243
MARKET ANALYSIS AND FORECAST    246
Over-the-Wire Microcatheter Market  246
Flow-Directed Microcatheter Market  248
Neurovascular Guiding Catheter Market   250
DRIVERS AND LIMITERS      252
Market Drivers     252
Market Limiters  253
COMPETITIVE MARKET SHARE ANALYSIS     254
NEUROVASCULAR GUIDEWIRE MARKET   258
INTRODUCTION      258
MARKET ANALYSIS AND FORECAST    259
DRIVERS AND LIMITERS      262
Market Drivers     262
Market Limiters  262
COMPETITIVE MARKET SHARE ANALYSIS     264
NEUROVASCULAR STENT MARKET   268
INTRODUCTION      268
MARKET OVERVIEW  270
MARKET ANALYSIS AND FORECAST    272
Traditional Neurovascular Stent Market   272
Flow Diversion Stent Market   273
Intrasaccular Stent Market    274
DRIVERS AND LIMITERS      276
Market Drivers     276
Market Limiters  278
COMPETITIVE MARKET SHARE ANALYSIS     279
BALLOON OCCLUSION DEVICE MARKET   283
INTRODUCTION      283
MARKET ANALYSIS AND FORECAST    284
DRIVERS AND LIMITERS      286
Market Drivers     286
Market Limiters  286
COMPETITIVE MARKET SHARE ANALYSIS     288
ANEURYSM CLIP MARKET    291
INTRODUCTION      291
MARKET ANALYSIS AND FORECAST    293
Total Aneurysm Clip Market    293
Aneurysm Clip Market by Indication  295
Temporary Aneurysm Clip Market    296
Permanent Aneurysm Clip Market    297
Aneurysm Clip Market by Material   298
Titanium Aneurysm Clip Market     299
Cobalt Alloy Aneurysm Clip Market   300
DRIVERS AND LIMITERS      301
Market Drivers     301
Market Limiters  302
COMPETITIVE MARKET SHARE ANALYSIS     303
NEUROVASCULAR THROMBUS MANAGEMENT MARKET     307
INTRODUCTION      307
MARKET OVERVIEW  309
MARKET ANALYSIS AND FORECAST    312
Stent Retriever Market      312
Aspiration Catheter Market    313
DRIVERS AND LIMITERS      314
Market Drivers     314
Market Limiters  315
COMPETITIVE MARKET SHARE ANALYSIS     316
NEUROMODULATION DEVICE MARKET   320
INTRODUCTION      320
Spinal Cord Stimulation      320
Deep Brain Stimulation      321
Sacral Nerve Stimulation     322
Vagus Nerve Stimulation     323
Gastric Electric Stimulation    323
Dorsal Root Ganglion Stimulation    324
Responsive Neurostimulation   325
MARKET OVERVIEW  326
MARKET ANALYSIS AND FORECAST    329
Spinal Cord Stimulation Market     329
Spinal Cord Stimulation Generator Market by Battery Type  332
Rechargeable Spinal Cord Stimulation Generator Market  334
Non-Rechargeable Spinal Cord Stimulation Generator Market    335
Spinal Cord Stimulation Generator Market by Channel Type  336
Dual-Channel Spinal Cord Stimulation Generator Market  338
Tri & Quad-Channel Spinal Cord Stimulation Generator Market 339
Spinal Cord Stimulation Lead Market    340
Percutaneous Lead Market     342
Paddle and Surgical Lead Market     343
Spinal Cord Stimulation Implants by Application  344
Deep Brain Stimulation Market     345
Sacral Nerve Stimulation Market    346
Sacral Nerve Stimulation Generator Market by Battery Type 347
Rechargeable Sacral Nerve Stimulation Generator Market     349
Non-Rechargeable Sacral Nerve Stimulation Generator Market 350
Vagus Nerve Stimulation Market    351
Gastric Electric Stimulation Market  353
Dorsal Root Ganglion Stimulation Market  354
Responsive Neurostimulation Device Market   355
DRIVERS AND LIMITERS      356
Spinal Cord Stimulation Market    356
Market Drivers  356
Market Limiters  357
Deep Brain Stimulation Market    358
Market Drivers  358
Market Limiters  358
Sacral Nerve Stimulation Market    359
Market Drivers  359
Market Limiters  360
Vagus Nerve Stimulation Market    361
Market Drivers  361
Market Limiters  361
Gastric Electric Stimulation Market  362
Market Drivers  362
Market Limiters  362
Dorsal Root Ganglion Stimulation Market  363
Market Drivers  363
Market Limiters  363
Responsive Neurostimulation Device Market   364
Market Drivers  364
Market Limiters  364
COMPETITIVE MARKET SHARE ANALYSIS     366
INTRATHECAL PUMP MARKET    372
INTRODUCTION      372
MARKET ANALYSIS AND FORECAST    374
DRIVERS AND LIMITERS      377
Market Drivers     377
Market Limiters  378
COMPETITIVE MARKET SHARE ANALYSIS     379
STEREOTACTIC DEVICE MARKET    382
INTRODUCTION      382
MARKET OVERVIEW  384
MARKET ANALYSIS AND FORECAST    387
Frame-Based Stereotactic Device Market  387
Frameless Stereotactic Device Market    388
INSTALLED BASE ANALYSIS     389
Frame-Based Stereotactic Device Market  389
Frameless Stereotactic Device Market    390
DRIVERS AND LIMITERS      391
Market Drivers     391
Market Limiters  392
COMPETITIVE MARKET SHARE ANALYSIS     394
NEUROENDOSCOPY MARKET     399
INTRODUCTION      399
MARKET OVERVIEW  401
MARKET ANALYSIS AND FORECAST    404
Rigid Endoscope Market      404
Flexible Endoscope Market    405
Videoscope Market     406
Single-Use Endoscope Market   407
Neuroendoscopic Hand Instrument Market  408
Neuroendoscopy Disposables Market  409
DRIVERS AND LIMITERS      410
Market Drivers     410
Market Limiters  411
COMPETITIVE MARKET SHARE ANALYSIS     413
ULTRASONIC ASPIRATOR MARKET   417
INTRODUCTION      417
MARKET OVERVIEW  418
MARKET ANALYSIS AND FORECAST    420
Capital Equipment Market     420
Installed Base   421
Disposable Probe Tip Market   422
Disposable Tubing Market     423
DRIVERS AND LIMITERS      424
Market Drivers     424
Market Limiters  425
COMPETITIVE MARKET SHARE ANALYSIS     426
APPENDIX: INTRACEREBRAL HEMORRHAGE TREATMENT     429
INTRODUCTION      429
MARKET DRIVERS   431
ABBREVIATIONS      432
The Neurology Devices Market Report Suite| United States | 2022-2028 | MedSuite includes analysis on the following companies currently active in this market:
  • Medtronic
  • Abbott
  • Stryker
  • Boston Scientific
  • LivaNova
  • Nevro
  • MicroVention
  • Penumbra
  • Integra LifeSciences
  • Cerenovus
  • Axonics
  • Brainlab
  • NeuroPace
  • Aesculap
  • Mizuho
  • Q’apel Medical
  • Elekta
  • Karl Storz
among others.
List of Charts
Chart 1-1: Neurological Device Market by Segment, U S , 2021 – 2028     2
Chart 1-2: Neurological Device Market Overview, U S , 2021 & 2028     2
Chart 2-1: Multi-Scenario Neurological Device Market Forecast, U S , 2018 – 2028 (US$M)   38
Chart 5-1: Neurological Device Market by Segment, U S , 2018 – 2028    137
Chart 5-2: Leading Competitors, Neurological Device Market, U S , 2021   153
Chart 6-1: Neurological Procedures by Type, U S , 2018 – 2028      177
Chart 7-1: Cerebrospinal Fluid Management Market by Segment, U S , 2018 – 2028  198
Chart 7-2: Leading Competitors, Cerebrospinal Fluid Management Market, U S , 2021     218
Chart 8-1: Detachable Coil Market by Segment, U S , 2018 – 2028     222
Chart 8-2: Leading Competitors, Detachable Coil Market, U S , 2021    232
Chart 9-1: Liquid Embolic Market, U S , 2018 – 2028       235
Chart 9-2: Leading Competitors, Liquid Embolic Market, U S , 2021    240
Chart 10-1: Neurovascular Catheter Market by Segment, U S , 2018 – 2028     245
Chart 10-2: Leading Competitors, Neurovascular Catheter Market, U S , 2021     257
Chart 11-1: Neurovascular Guidewire Market, U S , 2018 – 2028     261
Chart 11-2: Leading Competitors, Neurovascular Guidewire Market, U S , 2021   267
Chart 12-1: Neurovascular Stent Market by Segment, U S , 2018 – 2028      271
Chart 12-2: Leading Competitors, Neurovascular Stent Market, U S , 2021     282
Chart 13-1: Balloon Occlusion Device Market, U S , 2018 – 2028     285
Chart 13-2: Leading Competitors, Balloon Occlusion Device Market, U S , 2021    290
Chart 14-1: Leading Competitors, Aneurysm Clip Market, U S , 2021    306
Chart 15-1: Neurovascular Thrombectomy Market by Segment, U S , 2018 – 2028  311
Chart 15-2: Leading Competitors, Neurovascular Thrombus Management Market, U S , 2021  319
Chart 16-1: Neuromodulation Device Market by Segment, U S , 2018 – 2028    328
Chart 16-2: Leading Competitors, Neuromodulation Device Market, U S , 2021    371
Chart 17-1: Intrathecal Pump Market, U S , 2018 – 2028     376
Chart 17-2: Leading Competitors, Intrathecal Pump Market, U S , 2021   381
Chart 18-1: Stereotactic Device Market by Segment, U S , 2018 – 2028   386
Chart 18-2: Leading Competitors, Stereotactic Device Market, U S , 2021      398
Chart 19-1: Neuroendoscopy Market by Segment, U S , 2018 – 2028    403
Chart 19-2: Leading Competitors, Neuroendoscopy Market, U S , 2021   416
Chart 20-1: Ultrasonic Aspirator Market by Segment, U S , 2018 – 2028   419
Chart 20-2: Leading Competitors, Ultrasonic Aspirator Market, U S , 2021      428
List of Figures
Figure 1-1: Neurological Device Market Share Ranking by Segment, U S , 2021 (1 of 2)       4
Figure 1-2: Neurological Device Market Share Ranking by Segment, U S , 2021 (2 of 2)       4
Figure 1-3: Companies Researched in this Report, U S , 2021   5
Figure 1-4: Factors Impacting the Neurological Device Market by Segment, U S  (1 of 2)      6
Figure 1-5: Factors Impacting the Neurological Device Market by Segment, U S  (2 of 2)      7
Figure 1-6: Recent Events in the Neurological Device Market, U S , 2018 – 2021   8
Figure 1-1: Neurological Device Procedures Covered 9
Figure 1-2: Neurological Device Markets Covered (1 of 2)     10
Figure 1-3: Neurological Device Markets Covered (2 of 2)     11
Figure 1-4: Key Report Updates      12
Figure 1-5: Version History 12
Figure 2-1: Neurological Device Market by Segment, Worst Case Scenario, U S , 2018 – 2028 (US$M) (1 of
3) 29
Figure 2-2: Neurological Device Market by Segment, Worst Case Scenario, U S , 2018 – 2028 (US$M) (2 of
3) 30
Figure 2-3: Neurological Device Market by Segment, Worst Case Scenario, U S , 2018 – 2028 (US$M) (3 of
3) 31
Figure 2-4: Neurological Device Market by Segment, Base Case Scenario, U S , 2018 – 2028 (US$M) (1 of
3) 32
Figure 2-5: Neurological Device Market by Segment, Base Case Scenario, U S , 2018 – 2028 (US$M) (2 of
3) 33
Figure 2-6: Neurological Device Market by Segment, Base Case Scenario, U S , 2018 – 2028 (US$M) (3 of
3) 34
Figure 2-7: Neurological Device Market by Segment, Best Case Scenario, U S , 2018 – 2028 (US$M) (1 of
3) 35
Figure 2-8: Neurological Device Market by Segment, Best Case Scenario, U S , 2018 – 2028 (US$M) (2 of
3) 36
Figure 2-9: Neurological Device Market by Segment, Best Case Scenario, U S , 2018 – 2028 (US$M) (3 of
3) 37
Figure 3-1: Neurology Disease Overview  42
Figure 4-1: Shunt Types    57
Figure 4-2: Cerebrospinal Fluid Management by Company    59
Figure 4-3: Detachable Coils by Company    61
Figure 4-4: Liquid Embolics by Company    63
Figure 4-5: Neurovascular Catheters by Company  65
Figure 4-6: Neurovascular Guidewires by Company 67
Figure 4-7: Neurovascular Stent by Company      69
Figure 4-8: Balloon Occlusion Devices by Company 71
Figure 4-9: Aneurysm Clip Devices by Company    73
Figure 4-10: Neurovascular Thrombus Management Devices by Company  76
Figure 4-11: Neuromodulation Devices by Company     81
Figure 4-12: Intrathecal Pumps Devices by Company     83
Figure 4-13: Stereotactic Devices by Company     86
Figure 4-14: Neuroendoscopy by Company  89
Figure 4-15: Ultrasonic Aspiration Devices by Company      90
Figure 4-16: Class 2 Device Recall Natus EDS3 CSF External Drainage System     91
Figure 4-17: Class 2 Device Recall Medtronic PS Medical CSFFlow Control Valves     91
Figure 4-18: Class 2 Device Recall MicroVention Terumo Microplex 10, Helical 10 Soft      92
Figure 4-19: Class 2 Device Recall MicroVention Terumo HydroFrame 10 and 18      92
Figure 4-20: Class 2 Device Recall MicroVention Terumo Microplex 10, Compass 10   92
Figure 4-21: Class 2 Device Recall MicroVention Terumo HydroSoft 10, HydroSoft 3D       93
Figure 4-22: Class 2 Device Recall GALAXY G3 Mini Microcoil Delivery System    93
Figure 4-23: Class 2 Device Recall C315HIS Delivery Catheter       94
Figure 4-24: Class 2 Device Recall MIVI Super 90 Guide Catheters   94
Figure 4-25:Class 2 Device Recall MAMBA Flex 135 Microcatheter   94
Figure 4-26: Class 2 Device Recall Intracranial Neurovascular Stent  95
Figure 4-27: Class 2 Device Recall MIVI Super 90 Guide Catheters   96
Figure 4-28: Class 2 Device Recall MAMBA Flex 135 Microcatheter  96
Figure 4-29:Class 2 Device Recall 6F Launcher Guide Catheter      96
Figure 4-30: Class 2 Device Recall Conquest PTA Balloon Dilatation Catheter     97
Figure 4-31:Class 2 Device Recall Merci Balloon Guide Catheters    97
Figure 4-32: Class 2 Device Recall Medtronic Wireless Recharger    98
Figure 4-33: Class 2 Device Recall Model B352000 Percept PC BrainSense Implantable Neurostimulator 98
Figure 4-34: Class 2 Device Recall A610     98
Figure 4-35: Class 2 Device Recall Percept PC Implantable Neurostimulator (INS)     98
Figure 4-36: Class 2 Device Recall KARL STORZ NEUROFIBERSCOPE  99
Figure 4-37: Class 2 Device Recall Karl Storz NeuroFiberscope      99
Figure 4-38: Class 2 Device Recall FLEXIBLE NEURO FIBERSCOPE     99
Figure 4-39: Class 2 Device Recall Stealth Autoguide Tracker, Model: 28248    100
Figure 4-40:Class 2 Device Recall Medtronic     100
Figure 4-41: Class 2 Device Recall Polaris Spectra Camera for StealthStation S7 System    100
Figure 4-42:Class 2 Device Recall Leksell Vantage Stereotactic System    100
Figure 4-43: Class 2 Device Recall Leksell Vantage Stereotactic System   101
Figure 4-44:Class 2 Device Recall ROSA Brain 3 0 Application Brain and ROSA One 3 1     101
Figure 4-45: Class 2 Device Recall Trident Endoscopic Ultrasonic Aspiration Needle (FNA)  102
Figure 4-46: Class 2 Device Recall Footswitch accessory     102
Figure 4-47: Class 2 Device Recall Leica M220 F12 103
Figure 4-48: Class 2 Device Recall Prometra Programmable Pump System 104
Figure 4-49: Class 2 Device Recall Medtronic Synchromed II Implantable Drug Infusion Pump    104
Figure 4-50: Class 2 Device Recall AXS Vecta 71 , Vecta 74 Aspiration Catheter      105
Figure 4-51: Class 1 Device Recall MINDFRAME CAPTURE(TM) LP Revascularization Device      105
Figure 4-52: Class 2 Device Recall Trevo XP ProVue System   105
Figure 4-53: The Effect of Lumbar CSF Drainage on the Neurologic Outcome Improvement in OHCA
Underwent TTM   107
Figure 4-54: Operative Procedures vs  Endovascular Neurosurgery for Untreated Pseudotumor Trial
(OPEN-UP)       107
Figure 4-55: Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension
(HYDROPTIC)     108
Figure 4-56: SMART - A Prospective, Multicenter Study Assessing the Embolization of Neurovascular
Lesions Using the Penumbra Smart Coil   109
Figure 4-57: Prospective, Randomized, Controlled, Open Label, All China, Multi-Center, Registration Trial
of the MICROPORT NEUROTECH Coil Embolization System for the Traetment of Intracranial Aneurysms
109
Figure 4-58: Transcatheter Leak Closure with Detachable Coils Following Incomplete Left Atrial
Appendage Closure Procedures (TREASURE)    110
Figure 4-59: Middle Meningeal Artery Embolization with Liquid Embolic Agent for Treatment of Chronic
Subdural Hematoma    111
Figure 4-60: Treatment of Cerebral Arteriovenous Malformations with SQUID Liquid Embolic Agent - The
CHOICE Study A Non-interventional, Prospective, Single-arm, International, Multicenter Study  111
Figure 4-61: quid Liquid Embolic Agent for the Embolization of Abdominopelvic Arterial Bleeding
Syndrome (SQUIDperi Study) (SQUIDperi)      112
Figure 4-62: Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous
Malformations    112
Figure 4-63: SMART - A Prospective, Multicenter Study Assessing the Embolization of Neurovascular
Lesions Using the Penumbra Smart Coil   113
Figure 4-64: Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps
for CSF Infusion   113
Figure 4-65: Inflammatory and Infectious Diseases of the Nervous System     114
Figure 4-66: Safety and Utility Profile of the Asahi Chikai Black 18 neurovascular guidewire in Large Vessel
Occlusive Stroke: SURE 18 Registry       115
Figure 4-67: Evaluation of Safety and Performance of the Neuroform AtlasTM Stent System for
Intracranial Aneurysm Treatment - Post Market Clinical Follow-up      116
Figure 4-68: Safety and Effectiveness of the Treatment of Wide Neck, Intracranial, Saccular Aneurysms
with the Next Generation Neuroform Stent System        116
Figure 4-69: MicroNet-covered Stent System for Stroke Prevention in All Comer Carotid Revascularization
(PARADIGM-EXT)  117
Figure 4-70: The Motor Network in Essential Tremor: Mechanisms of Therapy      118
Figure 4-71: Wearable Neuromodulation DeVice for the TrEatment of Alzheimer's Disease (WAVE-AD)
118
Figure 4-72: A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in
Children and Adolescents Visiting the Emergency Department    119
Figure 4-73: Minimally-invasive Surgery Versus Craniotomy in Patients with Supratentorial Hypertensive
Intracerebral Hemorrhage: A Multi-center Randomized Controlled Trial 120
Figure 4-74: Minimally Invasive Treatment of Hypertensive Basal Ganglia Hemorrhage by Transfrontal
Keyhole Neuroendoscopy     120
Figure 4-75: Phase I Study of Stereotactic Radiosurgery Dose Escalation for Brain Metastases    121
Figure 4-76: Cyberknife Radiosurgery for Patients with Brain Metastases Diagnosed With Either SPACE or
MPRAGE Sequence - A Prospective Randomized Evaluation of Response and Toxicity     121
Figure 4-77: Phase I TITE-CREM Dose Escalation Study of Fractionated Stereotactic Radiation Therapy
(FSRT) in Unresected Brain Metastases    122
Figure 4-78: Safety and Effectiveness of SOFIA™/SOFIA™ PLUS for Direct Aspiration in Acute Ischemic
Stroke (SESAME)  123
Figure 4-79: Feasibility Study of RapidPulseTM Aspiration System as Frontline Approach for Stroke
Patients (RapidPulseFS)  123
Figure 4-80: A Single-Arm Objective Performance Criteria Trail For Intracranial Thrombus Aspiration
Catheter    124
Figure 4-81: A Safety and Efficacy Study of NicaPlant® in Aneurysmal Subarachnoid Haemorrhage
Patients Undergoing Aneurysm Clipping   125
Figure 4-82: Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting
and Preserving Terminated Nerve Ends   126
Figure 4-83: Regional Strategy for Transfer for Mechanical Thrombectomy (START)       127
Figure 4-84: Evaluation of Mechanical Thrombectomy in Acute Ischemic Stroke Related to a Distal
Arterial Occlusion (DISCOUNT)     127
Figure 5-1: Neurological Device Market by Segment, U S , 2018 – 2028 (US$M) (1 of 3)    134
Figure 5-2: Neurological Device Market by Segment, U S , 2018 – 2028 (US$M) (2 of 3)    135
Figure 5-3: Neurological Device Market by Segment, U S , 2018 – 2028 (US$M) (3 of 3)    136
Figure 5-4: Leading Competitors, Neurological Device Market, U S , 2021 (1 of 3)    150
Figure 5-5: Leading Competitors, Neurological Device Market, U S , 2021 (2 of 3)    151
Figure 5-6: Leading Competitors, Neurological Device Market, U S , 2021 (3 of 3)    152
Figure 5-7: SWOT Analysis, Abbott   166
Figure 5-8: SWOT Analysis, B  Braun       167
Figure 5-9 SWOT Analysis, Boston Scientific      168
Figure 5-10: SWOT Analysis, Integra LifeSciences  169
Figure 5-11: SWOT Analysis, LivaNova     170
Figure 5-12: SWOT Analysis, Medtronic    171
Figure 5-13: SWOT Analysis, MicroVention      172
Figure 5-14: SWOT Analysis, Mizuho       173
Figure 5-15: SWOT Analysis, Stryker       174
Figure 6-1: Neurological Procedures by Type, U S , 2018 – 2028 (1 of 2)   175
Figure 6-2: Neurological Procedures by Type, U S , 2018 – 2028 (2 of 2)   176
Figure 6-3: Cerebrospinal Fluid Shunting Procedures, U S , 2018 – 2028   179
Figure 6-4: Interventional treatment of Saccular Aneurysm Procedures by Modality, U S , 2018 – 2028 181
Figure 6-5: Liquid Embolization of AVM Procedures, U S , 2018 – 2028   182
Figure 6-6: Thrombus Management Procedures by Modality, U S , 2018 – 2028     184
Figure 6-7: Neuromodulation Implantation Procedures, U S , 2018 – 2028 (1 of 2)   186
Figure 6-8: Neuromodulation Implantation Procedures, U S , 2018 – 2028 (2 of 2)   187
Figure 6-9: Spinal Cord Stimulation Implantation Procedures, U S , 2018 – 2028    188
Figure 6-10: Deep Brain Stimulation Implantation Procedures, U S , 2018 – 2028    189
Figure 6-11: Intrathecal Pump Procedures, U S , 2018 – 2028      191
Figure 6-12: Stereotactic Surgery Procedures, U S , 2018 – 2028   192
Figure 6-13: Ultrasonic Aspiration Procedures, U S , 2018 – 2028  193
Figure 7-1: Cerebrospinal Fluid Management Market by Segment, U S , 2018 – 2028 (US$M)     197
Figure 7-2: Cerebrospinal Fluid Shunt Market by Segment, U S , 2018 – 2028   200
Figure 7-3: Total Cerebrospinal Fluid Shunt Market, U S , 2018 – 2028    201
Figure 7-4: Adjustable Pressure Cerebrospinal Fluid Shunt Market, U S , 2018 – 2028      203
Figure 7-5: Fixed Pressure Cerebrospinal Fluid Shunt Market, U S , 2018 – 2028     205
Figure 7-6: Cerebrospinal Fluid External Drainage System Market by Segment, U S , 2018 – 2028 206
Figure 7-7: Total Cerebrospinal Fluid External Drainage System Market, U S , 2018 – 2028  207
Figure 7-8: Ventricular Drainage System Market, U S , 2018 – 2028      209
Figure 7-9: Lumbar and Ventricular Drainage System Market, U S , 2018 – 2028     210
Figure 7-10: Leading Competitors, Cerebrospinal Fluid Management Market, U S , 2021   217
Figure 8-1: Detachable Coil Market by Segment, U S , 2018 – 2028 (US$M)     221
Figure 8-2: Total Detachable Coil Market, U S , 2018 – 2028       223
Figure 8-3: Bare Platinum Detachable Coil Market, U S , 2018 – 2028     224
Figure 8-4: Coated Detachable Coil Market, U S , 2018 – 2028     225
Figure 8-5: Leading Competitors, Detachable Coil Market, U S , 2021     231
Figure 9-1: Liquid Embolic Market, U S , 2018 – 2028       234
Figure 9-2: Leading Competitors, Liquid Embolic Market, U S , 2021      239
Figure 10-1: Neurovascular Catheter Market by Segment, U S , 2018 – 2028    244
Figure 10-2: Over-the-Wire Microcatheter Market, U S , 2018 – 2028    247
Figure 10-3: Flow-Directed Microcatheter Market, U S , 2018 – 2028     249
Figure 10-4: Neurovascular Guiding Catheter Market, U S , 2018 – 2028  251
Figure 10-5: Leading Competitors, Neurovascular Catheter Market, U S , 2021      256
Figure 11-1: Neurovascular Guidewire Market, U S , 2018 – 2028   260
Figure 11-2: Leading Competitors, Neurovascular Guidewire Market, U S , 2021     266
Figure 12-1: Neurovascular Stent Market by Segment, U S , 2018 – 2028 (US$M)    270
Figure 12-2: Traditional Neurovascular Stent Market, U S , 2018 – 2028  272
Figure 12-3: Flow Diversion Stent Market, U S , 2018 – 2028      273
Figure 12-4: Intrasaccular Stent Market, U S , 2018 – 2028   275
Figure 12-5: Leading Competitors, Neurovascular Stent Market, U S , 2021     281
Figure 13-1: Balloon Occlusion Device Market, U S , 2018 – 2028   284
Figure 13-2: Leading Competitors, Balloon Occlusion Device Market, U S , 2021     289
Figure 14-1: Total Aneurysm Clip Market, U S , 2018 – 2028       294
Figure 14-2: Aneurysm Clip Market by Indication, U S , 2018 – 2028 (US$M)    295
Figure 14-3: Temporary Aneurysm Clip Market, U S , 2018 – 2028  296
Figure 14-4: Permanent Aneurysm Clip Market, U S , 2018 – 2028  297
Figure 14-5: Aneurysm Clip Market by Material, U S , 2018 – 2028 (US$M)     298
Figure 14-6: Titanium Aneurysm Clip Market, U S , 2018 – 2028    299
Figure 14-7: Cobalt Alloy Aneurysm Clip Market, U S , 2018 – 2028      300
Figure 14-8: Leading Competitors, Aneurysm Clip Market, U S , 2021     304
Figure 14-9: Leading Competitors, Aneurysm Clip Market by Indication, U S , 2021   305
Figure 14-10: Leading Competitors, Aneurysm Clip Market by Material, U S , 2021   305
Figure 15-1: Neurovascular Thrombus Management Market by Segment, U S , 2018 – 2028     310
Figure 15-2: Stent Retriever Market, U S , 2018 – 2028      312
Figure 15-3: Aspiration Catheter Market, U S , 2018 – 2028       313
Figure 15-4: Leading Competitors, Neurovascular Thrombus Management Market, U S , 2021    318
Figure 16-1: Neuromodulation Device by Segment, U S , 2018 – 2028 (US$M)       327
Figure 16-2: Spinal Cord Stimulation Market by Segment, U S , 2018 – 2028 (US$M)       330
Figure 16-3: Total Spinal Cord Stimulation Market, U S , 2018 – 2028     331
Figure 16-4: Spinal Cord Stimulation Generator Market by Battery Type, U S , 2018 – 2028 (US$M)     333
Figure 16-5: Rechargeable Spinal Cord Stimulation Generator Market, U S , 2018 – 2028   334
Figure 16-6: Non-Rechargeable Spinal Cord Stimulation Generator Market, U S , 2018 – 2028    335
Figure 16-7: Spinal Cord Stimulation Generator Market by Channel Type, U S , 2018 – 2028 (US$M)    337
Figure 16-8: Dual-Channel Spinal Cord Stimulation Generator Market, U S , 2018 – 2028   338
Figure 16-9: Tri & Quad-Channel Spinal Cord Stimulation Generator Market, U S , 2018 – 2028   339
Figure 16-10: Spinal Cord Stimulation Lead Market, U S , 2018 – 2028    341
Figure 16-11: Percutaneous Lead Market, U S , 2018 – 2028       342
Figure 16-12: Paddle and Surgical Lead Market, U S , 2018 – 2028  343
Figure 16-13: Spinal Cord Stimulation Implants by Application, U S , 2021 344
Figure 16-14: Deep Brain Stimulation Market, U S , 2018 – 2028   345
Figure 16-15: Total Sacral Nerve Stimulation Market, U S , 2018 – 2028   346
Figure 16-16: Sacral Nerve Stimulation Generator Market by Battery Type, U S , 2018 – 2028 (US$M)   348
Figure 16-17: Rechargeable Sacral Nerve Stimulation Generator Market, U S , 2018 – 2028      349
Figure 16-18: Non-Rechargeable Sacral Nerve Stimulation Generator Market, U S , 2018 – 2028  350
Figure 16-19: Vagus Nerve Stimulation Market, U S , 2018 – 2028  352
Figure 16-20: Gastric Electric Stimulation Market, U S , 2018 – 2028     353
Figure 16-21: Dorsal Root Ganglion Stimulation Market, U S , 2018 – 2028     354
Figure 16-22: Responsive Neurostimulation Device Market, U S , 2018 – 2028      355
Figure 16-23: Leading Competitors, Neuromodulation Device Market, U S , 2021    370
Figure 17-1: Intrathecal Pump Market, U S , 2018 – 2028    375
Figure 17-2: Leading Competitors, Intrathecal Pump Market, U S , 2021  380
Figure 18-1: Stereotactic Device Market by Segment, U S , 2018 – 2028   385
Figure 18-2: Frame-Based Stereotactic Device Market, U S , 2018 – 2028 387
Figure 18-3: Frameless Stereotactic Device Market, U S , 2018 – 2028    388
Figure 18-4: Installed Base, Frame-Based Stereotactic Device Market, U S , 2018 – 2028   389
Figure 18-5: Installed Base, Frameless Stereotactic Device Market, U S , 2018 – 2028      390
Figure 18-6: Leading Competitors, Stereotactic Device Market, U S , 2021 397
Figure 19-1: Neuroendoscopy Market by Segment, U S , 2018 – 2028    402
Figure 19-2: Rigid Endoscope Market, U S , 2018 – 2028     404
Figure 19-3: Flexible Endoscope Market, U S , 2018 – 2028   405
Figure 19-4: Videoscope Market, U S , 2018 – 2028     406
Figure 19-5: Single-Use Endoscope Market, U S , 2018 – 2028     407
Figure 19-6: Neuroendoscopic Hand Instrument Market, U S , 2018 – 2028     408
Figure 19-7: Neuroendoscopy Disposables Market, U S , 2018 – 2028    409
Figure 19-8: Leading Competitors, Neuroendoscopy Market, U S , 2019  415
Figure 20-1: Ultrasonic Aspirator Market by Segment, U S , 2018 – 2028  418
Figure 20-2: Capital Equipment Market, U S , 2018 – 2028   420
Figure 20-3: Installed Base, Ultrasonic Aspirator Market, U S , 2018 – 2028     421
Figure 20-4: Leading Competitors, Ultrasonic Aspirator Market, U S , 2021     427

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary FREE

Neurological Devices Market Size, Share & COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Neurovascular Catheters, Neuromodulation Devices, and 12 more

$7,995$9,995

iData’s U.S. neurology devices market MedSuite covers 14 markets and COVID-19 impacts. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

  • 2022
  • 10 Years
  • United States
  • 09/09/2022
  • 432
  • MedSuite
Clear
Request Sample Sheets Request Customization